X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/29/2871632/0/en/ACELYRIN-INC-to-Report-First-Quarter-2024-Financial-Results-and-Corporate-Update-on-May-13-2024.html
https://www.globenewswire.com/news-release/2024/03/28/2854476/0/en/ACELYRIN-INC-Reports-Full-Year-2023-Financial-Results-and-Recent-Highlights.html
https://www.globenewswire.com/news-release/2024/03/20/2849228/0/en/ACELYRIN-INC-Announces-Positive-Phase-1-2-Proof-of-Concept-Data-for-Lonigutamab-First-Subcutaneous-Anti-IGF-1R-to-Demonstrate-Clinical-Responses-in-Thyroid-Eye-Disease.html
https://www.fiercebiotech.com/biotech/acelyrin-adds-proof-concept-ted-data-recent-readout-pile-cementing-direct-challenge-amgen
https://www.fiercebiotech.com/biotech/acelyrin-rebounds-psoriatic-arthritis-victory
https://www.globenewswire.com//news-release/2024/03/11/2843753/0/en/ACELYRIN-INC-Announces-Positive-Top-line-Results-from-Its-Global-Phase-2b-3-Clinical-Trial-of-Izokibep-in-Psoriatic-Arthritis.html
https://www.globenewswire.com//news-release/2024/02/15/2830372/0/en/ACELYRIN-INC-Appoints-Agnes-Lee-as-Senior-Vice-President-Investor-Relations-and-Corporate-Communications.html
https://www.globenewswire.com//news-release/2023/12/20/2799659/0/en/ACELYRIN-INC-Appoints-Lynn-Tetrault-to-Board-of-Directors.html
https://endpts.com/cro-fortrea-disputes-the-accuracy-of-acelyrins-claims-about-immunology-drug-trial-conduct/
https://www.fiercebiotech.com/biotech/acelyrin-blames-cro-error-shocking-phase-3-failure-sent-shiver-through-biotech-ipo-market
Market Place
Share 
